In the Media

As a a fellowship-trained breast specialist and board-certified general surgeon with a strong track record of successfully diagnosing and treating patients with breast cancer and benign diseases of the breast, Dr. Sadia Khan is a trusted source among her peers.  She has been published in countless prominent medical journals and has been a highly sought-after speaker at numerous national conferences for her expertise in the most advanced breast cancer treatments available to date.


Are We Overtreating Ductal Carcinoma In Situ (DCIS)?

At the 2016 annual American Society of Breast Surgeons Meeting held in Dallas, TX, Dr. Khan presented the results of a study that found that patients with all types of DCIS, regardless of grade when treated with inadequate surgical excision, had high recurrence rates. The recurrence rates were too high to allow watchful waiting as a safe option at this time. This is the only objective data published or reported until the long-term clinical trials are completed, which will be at least 10 years. We are hoping this work will spread the word and help clear up misconceptions for patients and doctors. It confirms that the watch and wait theory can be dangerous and something that should only be offered in the setting of a clinical trial.

Oncoplastic Split Reduction with Intraoperative Radiation Therapy

Silverstein, M.J., Savalia, N.B., Khan, S. et al. Ann Surg Oncol (2015) 22: 3405.

Extreme Oncoplasty: Breast Conservation for Patients Who Need Mastectomy

Silverstein, Melvin J et al. “Extreme Oncoplasty: Breast Conservation for Patients Who Need Mastectomy.” The Breast Journal 21.1 (2015): 52–59. PMC. Web. 25 Aug. 2017.

Intraoperative Radiation Using Low-Kilovoltage X-Rays for Early Breast Cancer: A Single Site Trial

Silverstein, M.J., Epstein, M.S., Lin, K. et al. Ann Surg Oncol (2017).

Next, read Meet Dr. Khan